As other medical imaging vendors are tightening their belts, NovaRad is racking up sales, installing five to eight RIS/PACS a month. And it’s not a passing thing, according to Paul Shumway, NovaRad vice president of operations and marketing. He expects the firm to maintain this pace through 2009. The reason? The company’s RIS/PACS help hospitals and imaging facilities minimize costs and maximize profits.
As other medical imaging vendors are tightening their belts, NovaRad is racking up sales, installing five to eight RIS/PACS a month. And it’s not a passing thing, according to Paul Shumway, NovaRad vice president of operations and marketing. He expects the firm to maintain this pace through 2009. The reason? The company’s RIS/PACS help hospitals and imaging facilities minimize costs and maximize profits.
“People are looking for ways to save money and to make money,” Shumway said. “Our products do that.”
The NovaRad PACS is easy to install, use, and learn. It doesn’t require a big IT department, a full-time PACS administrator, or even an IT staff to administer. Its RIS is similarly easy to handle. “And it helps facilities manage their workflow and run their business better,” he said.
Because time means money, the company’s latest release, a combined NovaRIS/NovaPACS 7.1 release, adds features that improve productivity. Automatic hanging protocol options allow two different protocols for viewing a single study alone or alongside a comparison study, an image series to start in cine, multiplanar reformatting, or other advanced formats. Also, the same study can be manipulated or viewed in different windows or levels.
New controls for faster scrolling eliminate the need to scroll through every image, allowing huge data sets to be processed more quickly.
“There is a need for radiologists to be more efficient,” Shumway said. “They need to have fast turnaround times because the lifeblood of any facility is to recruit and maintain a base of referring physicians, and there is no reason why a facility can’t accelerate report turnaround times.”
RIS management reports show where a facility is making money and where it isn’t.
“If you are going to buy a new modality, you should know which modality makes you the most money,” he said. “If you want to grow your business, you should know who is sending referrals or why a particular referring physician stops sending patients.”
NovaPACS/RIS is sold as a turnkey solution under a service contract that covers software, support, and upgrades for a flat monthly fee based on a facility’s annual image load.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.